Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_274590824

J&J hit by $1bn hip implant lawsuit

December 2, 2016
Medical Communications J&J, JJ, lawsuit

Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …

News
astrazeneca_building_white

AstraZeneca seals $1 billion deal with Bicycle Therapeutics

December 2, 2016
Medical Communications, Sales and Marketing AstraZeneca, Bicycle Therapeutics

Bicycle Therapeutics, Cambridge-based British biotech firm, has announced that it has signed a deal that could potentially be worth over …

News
merckincweb1

NICE approves MSD’s Keytruda for new cancer indication

December 1, 2016
Medical Communications, Sales and Marketing MSD, NICE, keytruda

The National Institute of Health and Care Excellence (NICE) has announced its recommendation of MSD’s immunotherapy drug Keytruda (pembrolizumab) for …

News
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …

Appointment
takeda_tokyo_hq

Takeda to build €100 million dengue vaccine manufacturing plant

December 1, 2016
Manufacturing and Production, Medical Communications Takeda, dengue, phase 3

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …

News
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …

News
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …

News
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …

News
shutterstock_291014192

NICE recommends GSK’s “first-in-class” asthma drug

November 30, 2016
Sales and Marketing GSK, NICE, Nucala, asthma

NICE has announced its recommendation of GSK’s “first-in-class” biologic Nucala (mepolizumab) as an extra option for the treatment of adults …

News
blood-75302_640

Researchers develop capsule-based haemophilia treatment tech

November 30, 2016
Research and Development University of Texas, haemophilia

Researchers at the University of Texas have developed a new method for treating haemophilia B which utilises a biodegradable oral …

News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016
Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …

News
advanced_manufacturing_building_site_uon

£25m flagship manufacturing & research facility for University of Nottingham

November 30, 2016
Manufacturing and Production, Research and Development University of Nottingham

Earlier this month, the University of Nottingham began work on a ‘pioneering’ Advanced Manufacturing Building. The £25 million, 9,011 square-metre …

News
humira_abbott_

Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016
Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …

News
shutterstock_204190579

MDMA trials get FDA backing for PTSD treatment

November 30, 2016
Research and Development FDA, MDMA, PTSD

The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …

News
actinium_pharma

Actinium snatches up ex-Novartis clinical manager

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment

Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …

Appointment

NICE recommends 4p breast cancer drug for healthy women

November 29, 2016
Research and Development, Sales and Marketing NICE, anastrozole, breast cancer

NICE has published new draft guidance calling for women with a strong family history of breast cancer to be offered …

News
ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …

Appointment

PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …

News
Press release
cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016
Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …

News
shutterstock_232245868

Personalised medicine to drive global lung cancer market to 2020

November 29, 2016
Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer

According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026